Female Infertility study: Denosumab vs PBS
Official title Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis
ClinicalTrials.gov ID: NCT07546552
What this study is testing
- What it's testing
- The study will examine how RANKL, a protein involved in bone and egg development, affects ovarian function and egg maturation. It will also look at whether RANKL levels in follicle fluid can indicate ovarian health.
- What's involved
- Participants will have their eggs and follicle fluid examined, and some may receive a drug that blocks RANKL. The study will involve lab tests and possibly injections of the drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Female in the age of 18 or above, Normal AMH-value, able to give concent
You likely can't join if
- Patients who have had autotransplanted ovarian tissue
The study team makes the final eligibility decision.
Where it is enrolling
- Skive, Midt Jylland, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Skive, Midt Jylland, Denmark. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.